Amplification of oncogenes has been found to be an important prognostic factor in behavior of patients' malignancies. In this study we have used new gel electrophoresis techniques to follow the location of amplified c-myc oncogene sequences in HL-60 promyelocytic leukemia cells. In passages 46-62 of the cells, the cells contain amplified c-myc sequences on submicroscopic circular extrachromosomal DNA (episomes). With increased passages in culture (passages 63-72) the cells lose the episome c-myc sequences with a shift of those sequences to double minutes. With additional passage in culture, the c-myc shifts from the double minutes to a chromosomal site der(5)t(5; 17Xqll.2;q?11.2). Concomitant with the shift of the c-myc sequences into the chromosomal compartment is a phenotypic change of a shortened cell-doubling time. These studies provide the first molecular evidence of a progression from a submicroscopic location for amplified oncogene sequences to a chromosomal location for the amplified sequences. This molecularly documented model can now be used to test various strategies to prevent incorporation of extrachromosomally located oncogene sequences into chromosomal sites. Prevention of integration of the oncogene sequences into chromosomal sites could modulate progression of patients'
Introduction
Gene amplification is a mechanism whereby transformed cells generate multiple copies of discrete regions of their genome. This amplification gives an increase in titers ofgene product(s) coded for within the amplified regions (1, 2) . Gene amplification has been demonstrated to be important in vitro and in vivo for resistance of patients' tumors to antineoplastic agents (via amplification ofdrug resistance genes) and for progression of patients' tumors (via amplification of oncogenes) (3) (4) (5) (6) (7) .
There are two cytogenetic manifestations of gene amplifi-cation. These include double minutes (DMs)' and homogeneously staining regions (HSRs) (8, 9) . Amplified drug resistance genes and amplified oncogenes have been localized to these structures. DMs were first described by Spriggs et al. in 1962 (10) . They are extrachromosomal chromatin bodies which lack centromeres and consequently have unequal separation at cell division. DMs have a wide variation in size even in a specific cell line. In addition, there is also a great variation in the number of DMs per cell (8, 9) .
HSRs were first described by Biedler and Spengler in 1976 (1 1, 12) . HSRs are an intrachromosomal abnormality in which regions of chromosomes stain in a uniform manner rather than in the usual differential banding pattern characteristic of G-band preparations. Within a cell line, HSRs tend to occur most commonly on specific chromosomes. Like DMs, HSRs appear to replicate early in S phase.
The origin of DMs is unclear. They have been considered as artifacts, microbial contamination, breakdown products of chromosomes, or fragments of HSRs (1, 13, 14) . The origin of HSRs is also unclear. There is some evidence that suggest HSRs may be generated by unequal crossing over between sister chromatids ( 15, 16) . Another mechanism involves saltatory replication whereby replication can be initiated at the same origin a number of times during one replication. Multiple initiations of replication generates an "onion skin" structure which together with recombination into the chromosome could generate duplicated sequences at the site of the specific gene ( 17) . Several investigators have documented, using cytogenetic methods in a variety of systems, that HSRs appear to arise from a chromosomal integration of DMs (see discussion below).
In recent months some new molecular evidence has been reported which may give a clue as to the origin of both DMs and HSRs. In a Chinese hamster ovary (CHO) cell line resistant to the antineoplastic agent N-phosphonacetyl-L-aspartate (based on amplification of the CAD gene), Carroll and col- leagues (18) have reported no chromosomal localization for the amplified CAD sequence but rather localization of the sequences on replicating circular submicroscopic supercoiled DNA. The same team has provided molecular and cytogenetic evidence that these circular DNAs (termed episomes) replicate and form double minutes in that CHO line (19) . Episomes containing drug resistant genes have now also been documented to be present in human tumor cells with amplification of the dihydrofolate reductase gene (20) (21) (22) and with amplification of the multidrug resistance gene (22, 23) .
Most recently, we have reported that passages 36-46 of the HL-60 human promyelocytic leukemia line, which has amplified copies of the c-myc oncogene, has those copies ofthe gene located on extrachromosomal replicating supercoiled circular DNA (episomes) 250 kbp in size (24) . In the present study, we have used molecular and cytogenetic techniques to follow the fate of those episomal elements as the HL-60 cells are passaged in tissue culture. We have found that with increasing passage in culture the c-myc-containing episomes are replaced by c-myc-containing DMs. With additional time the c-myc sequences on the DMs move from their extrachromosomal site and integrate into the short arm of the der (5) (25) . This cell line contains approximately 16-32 copies of the c-myc oncogene (26) . To establish subclones from the parental cell line, the cells were diluted so that approximately three to five cells were placed in each well of 96-well titer plates. The subclones were grown at 37°C in 5% CO2 in RPMI medium enriched with 20% FBS. A total of 186 wells were initially seeded. The cells from 12 of these wells were selected for expansion. The subclones selected for expansion had the best percent recovery of episomal DNA by the alkaline lysate method described below. After several population doublings (see below), cells were transferred to six-well dishes and then to T-25 flasks. Growth medium was changed to RPMI + 10% FBS in the flasks and cells were diluted 1:4 with the fresh medium once per week. Each of the subclones was numbered and continued in passage. Two of the subclones (nos. 173 and 161) were selected for serial molecular analysis, again based on the greatest intensity of the c-myc signal (on Southern blots) for form I (supercoiled episome) in those subclones (see below).
As a control cell line, we utilized the C5R500 CHO cell line (18) kindly supplied by Dr (18, 24) . Samples were then incubated for 30 min at 30°C and then neutralized with 0.4 ml of 1.0 M Tris HCI, pH 7.0 (all chemicals from Sigma Chemical Co., St. Louis, MO). Lysates were treated with 0.3 ml of SM NaCl and 14 Al of 20 mg/ml proteinase K (Sigma Chemical Co.) and incubated for 30 min at 37°C. Phenol (saturated with 0.2 M NaCl, 0.2 M Tris HCI at pH 8) (0.8 ml) was added, samples were mixed, and lysates were spun at 10,000 g for 10 min at 40C. Aqueous phases were transferred to new tubes, 2.5 vol of 100% ethanol were added, and samples were stored at -20'C overnight. DNA was precipitated by centrifugation at 10,000 g for 10 min at 4VC, rinsed with 1 ml of 70% ethanol, spun-dried, and resuspended in TE buffer. Samples were made 5% with respect to glycerol for electrophoresis.
Preparation and irradiation ofDNA in agarose blocks Cells were harvested, rinsed with PBS, and suspended in PBS at a density of 2.5 X 107 cells/ml. Cell suspensions were mixed with an equal volume of molten (550C) 1% low melting point agarose (SeaPlaque, FMC Corporation, Rockland, ME) in PBS and pipetted in 40-Ad aliquots (5 X 105 cells) into a rubber-based block-forming mold (27) . Blocks were allowed to harden and were placed in 1 5-ml culture tubes containing 2 ml of 1% Sarkosyl (Sigma Chemical Co.), 100 mM EDTA. Proteinase K (2 mg/ml) was added, the blocks were incubated for 24 h at 550C, rinsed twice with 10 ml of TE, and stored in TE at 4VC. Blocks were placed in 100 ul ofTE in 1 .5-ml microfuge tubes, and irradiated by '37Cs source (Gamma Cell 40, Atomic Energy of Canada Ltd., Ottawa, Canada) at a dose of 1.2 Gy/min for 6 min before electrophoresis.
DNA electrophoresis
Alkaline lysate DNA was electrophoresed in 0.8% agarose (Ultra Pure, Bethesda Research Laboratories, Gaithersburg, MD) using electrophoretic gels run in 45 by either field inversion gel electrophoresis (FIGE, resolving molecules below 1,000 kbp in size) or contour-clamped homogeneous electric field (CHEF, resolving molecules between 1,000 and 9,000 kbp in size) electrophoretic strategies (22, 28, 29) . FIGE was performed using a pulse switcher (Hoefer Scientific Instruments, San Francisco, CA) at 7 V/cm with a 3:1 forward to reverse pulse ratio in 1% agarose gels at 14°C with buffer recirculation. Pulses were ramped linearly from 3 s forward to 60 s forward over 12 h. CHEF electrophoresis was performed using a CHEF-II DR apparatus (Bio-Rad Laboratories, Richmond, CA) in 0.6% agarose gels at 14°C with 60-min pulses for 158 h at 50 V. Molecular weights between 200 and 1,100 kbp were determined by electrophoresing the chromosomes of Saccharomyces cerevisiae (Beckman Instruments, Inc., Houston, TX). Linearized Escherichia coli chromosome was used as a 4,800-kbp marker (30). Gels were stained for 30 min in 1.0 ,g/ml ethidium bromide and photographed with a red filter by transillumination with a 300-nm wavelength UV source.
DNA transfer and hybridization DNA was transferred from agarose gels to nylon-66 membranes (Nytran, Schleicher & Schuell, Inc., Keene, NH) by alkaline capillary transfer. Gels were equilibrated in 0.5 M NaOH, 1.5 M NaCl (transfer buffer) for 30 min at room temperature and placed on top oftwo pieces of wetted 3MM chromatography paper (Whatman Inc., Clifton, NJ) draped into transfer buffer. Nylon-66 membrane was wetted in water and then transfer buffer, placed on top of agarose gels, and covered with two pieces of 3MM paper wetted in transfer buffer. Six inches of paper towels and a 500-g weight were placed on top, and transfers were allowed to proceed overnight. Membranes were baked 30 min at 80°C in vacuo. Membranes were hybridized with specific DNA probes labeled with 32P by nick-translation kit (Boehringer Mannheim Biochemicals, Indianapolis, IN) to a specific activity of > 108 dpm/;g as previously described (31) . Hybridized membranes were matted with X-ray film (X-OMAT, Eastman Kodak Co., Rochester, NY) between two intensifying screens (Lightning Plus, DuPont Co., Wilmington, DE) and incubated at -70°C to generate autoradiograms.
DNA probes
Nylon membranes were probed for c-myc sequences using a commercially available probe (Oncor, Gaithersburg, MD) for the third exon of human c-myc. The PET 5 probe (a gift from Dr. GeoffWahl) was used to probe for mitochondrial DNA. DM and karyotype analysis HL-60 cells in log phase ofgrowth were harvested by a modification of the trypsin-hypotonic-colcemid (THC) technique of Hozier and Lindquist (32) . Cells were incubated in 10 ml of a 1:9 0.25% trypsin/0.075 M KCI solution containing 0.1 Mg/ml colcemid (Gibco Laboratories, Grand Island, NY) for 1 h at 370C. After fixation with 3:1 methanol/ acetic acid, cells were dropped on clean wet slides and dried on a 60C slide warmer. Slides for DM analysis were stained with 2% Giemsa (Harleco, EM Science, Gibbstown, NJ). Slides for karyotype analysis were aged at room temperature for 7-10 d or heated at 60C for 72 h before trypsin-Giemsa banding.
50 metaphase spreads from each passage were examined for the presence of DMs. The DMs were categorized by size on a scale of 1-5 ( l, just barely visible with IOOX oil immersion; and 5, just smaller than the width of a chromatid). The number of pairs in each size category was also recorded. A minimum of 20 metaphase spreads from each passage was also analyzed for karyotyping after trypsin-Giemsa banding. The cytogeneticist was blinded to the molecular probing results for each passage.
HL-60 in situ mapping ofc-myc adaptedfrom technique ofPinkel et al. (33) Metaphase spreads. HL-60 cells in log phase growth were incubated for 20 min in 10 Ag/ml ethidium bromide at 370C. Colcemid (0.1 ug/ml) was added, cells were incubated an additional 20 min, and cells were pelleted. Cell pellets were suspended in 370C 0.075 M KCI, incubated for 20 min, and pelleted again. Cell Chromosomes were denatured by immersing slides in 70% formamide (Sigma Chemical Co.), 2X SSC, pH 7, for 2 min at 70°C. Slides were quickly transferred to 70% ethanol for 1 min, followed by 85% ethanol and then 100% ethanol, also for 1 min, and then dried by air jet.
Biotin labeling ofc-myc probe. 1 Ag of pSVc-myc (a plasmid containing a simian virus promoter along with c-myc sequence) was labeled with biotin by incubation with 2.5 ul ofdCTP, dATP, and dGTP from the Boehringer Mannheim nick kit, in addition to 5 Ml of lOx nick buffer and 1 ,l of biotin-16-dUTP (Boehringer Mannhein). Tritiated dATP (1 Ad; 250,000 cpm) was also added to follow biotin incorporation. The nick volume was made up to 45 Ml, and 5 Al of nick enzyme was added. The reaction proceeded at 15°C for 90 min and was stopped by addition of 10 Ml of0.1 M EDTA. DNA was separated from unincorporated dNTPs by chromatography on BioGel P-60 resin (BioRad Laboratories) in TE, pH 7.5. Fractions were scintillation counted (3H window), and 400 Ml of labeled DNA (2.5 Ag/ml) was collected for hybridization to HL-60 chromosomes.
Hybridization. Deproteinated and denatured HL-60 metaphase chromosomes were hybridized with biotin-labeled pSVc-myc probe by incubation at 37°C at a concentration of 100 ng oflabeled probe/ml of hybridization mix (10% dextran sulfate, 50% formamide [Sigma Chemical Co.], 2X SSC, and 50 Mg/ml denatured herring testes DNA [Sigma Chemical Co.]) under a glass coverslip. Labeled probe and carrier DNA were denatured by making them 0.1 N with respect to NaOH and incubating at 370C for 10 min before addition to the hybridization mix. Hybridization mix (30 Ml per slide) was placed on slides warmed to 370C, and coverslips (24 X 50 mm) were placed on top and sealed with rubber cement. Hybridizations were allowed to proceed overnight at 370C in a tissue culture incubator, and slides were washed with three changes of 50% formamide, 2X SSC, pH 7, at 450C for 2 min each, once in room temperature 2X SSC for 2 min, and then placed in 0.1 M sodium phosphate, 0.1% NP-40, pH 8.0 (PN buffer) until ready for staining.
Slide staining. All subsequent manipulations were performed in a room with very low light levels. Slides were removed from PN buffer, drained briefly, and 75 MlA of 5 Mg/ml fluorescein-labeled avidin (Vector Laboratories, Inc., Burlingame, CA) in PN buffer containing 5% nonfat dry milk (PNM buffer) was added, followed by a glass coverslip (24 X 50 mm). The slide was incubated for 20 min at room temperature in a moist chamber, and then washed in three changes of PN buffer for 2 min each. Slides were drained, and 75 Ml of 5 Mg/ml biotinylated goat anti-avidin (Vector Laboratories, Inc.) in PNM buffer was incubated under a coverslip for 20 min at room temperature. Slides were washed in three changes of PN buffer, and cycles of avidin, anti-avidin, and then avidin labeling separated by PN buffer washes were repeated again. Slides were washed once again in three changes of PN buffer, drained well (but not dried), and stained with 22 Ml of antifade containing 0.2 Mg/ml propidium iodide covered with a no. 1 glass coverslip (24 X 50 mm).
Chromosomes could be viewed immediately by fluorescent scope at 64 power under oil using the appropriate filter (FITC). Metaphases were photographed with Ecktachrome 400 slide film (Eastman Kodak Co.) with 15-s exposures.
Borate banding. After fluorescent staining and photography, chromosomes were banded by soaking slides extensively in borate buffer and then staining in Giemsa (Harleco) diluted 1:3 in borate buffer. Chromosome morphology is very poor after proteinase K and denaturation/hybridization, but banding patterns could be determined for some metaphases.
Results
Fate ofepisomal DNA. As discussed above we have previously documented that passages 36-62 of HL-60 cells have c-myc sequences located on supercoiled extrachromosomal DNA -250 kbp in size (episomes). The parent HL-60 line and the series of 12 subclones of the HL-60 were reexamined to document that they indeed had c-myc sequences located on episomal DNA (Fig. 1) . As can be seen in this figure all 13 cell lines had evidence ofan episome containing c-myc sequence in early passages (48-62) of the cells.
Two ofthese subclones (nos. 173 and 16 1) were followed in serial passages for the presence of c-myc on episomes. As can be seen in Fig. 2 , there was a decline in the amount of c-myc located on episomal DNA from an average of 400 density units in passage 63 cells down to essentially no c-myc present on episomal DNA by passage 73. Fig. 3 provides molecular evidence for this finding in one of the subclones (clone no. 173). Thus, with increasing passage number, the amount of c-myc present on episomal DNA was declining even though the total c-myc present in the cell line was staying about the same (13-fold amplification). Thus the c-myc sequences must have been shifting out ofthe episomal compartment into some other compartment.
As has been discussed in the introduction, Carroll and colleagues (19) the cells were passaged under selective pressure with the drug N-phosphonacetyl-L-aspartate. To determine if the c-myc sequence in the HL-60 cells may have transferred to DM DNA we examined metaphase spreads of each passage of subclones 173 and 161 to determine whether or not DMs were present. As can be seen in Fig. 4 , the percentage of HL-60 cells with DMs increased from about 20% at passage 60 to about 75% by passage 68. The average number ofDMs per cell also increased between passages 60 and 68 (see Fig. 4 ). However, with further following of these cells, by passage 74 the DMs essentially disappeared from the HL-60 cell (see Fig. 4 ). The karyotype was also noted to change with increasing cell passage. Chromosome analysis of passages 60-63 revealed a modal chromosome number of 45 with the following karyotype: 45,X,-X, -5,-17,+ 18, 9p-, 10p+, 14q-, 16+,16q+, +der (5) The duplicated der(5) appeared to have a slightly larger short arm region in some cells. This duplicated chromosome may have arisen by a non-disjunction event. By passage 75, 90% of cells were from the stem line 2 and practically no DMs were seen. These surprising results were studied at the molecular level to ascertain what was happening to the c-myc sequences.
To determine whether c-myc sequences were located on the double-minute DNA we utilized a new gel technique suited for isolation of large (1-9 mbp)-sized DNA. DMs visible on light microscopy are thought to be at least 1-2 mbp in size. The new gel technique is called CHEF electrophoresis (28, 29) . This technique was performed on passages of the HL-60 cells known to contain DMs (passages 64-72) and cells in which DMs could no longer be detected cytogenetically (passage 74). As can be seen in Fig. 5 , there are distinct c-myc containing species at sizes of 1.5 mpb and at approximately twice that p64 p67 p71 p73 p74 p64 p66 p71
size. These are the appropriate sizes for double-minute DNA (30). Double-minute DNA running in this position has also been described for other cell lines (30). Also ofnote in Fig. 5 is that the signal intensity for the double-minute DNA signal appears to decrease with increasing passage number. However, the intensity of signal in the zone of compression increases in intensity. The zone of compression contains very large DNA molecules possessing c-myc sequences. These probably represent chromosomal incorporation of the c-myc sequence. To explore that possibility we have performed in situ hybridizations on these later passage cells. As can be seen in Fig. 6 , c-myc has integrated into the short arm of the duplicated derived chromosome 5,der (5) (34) have previously documented that amplified c-myc was localized to the long arm of a marker chromosome M3q+, which appears to be similar to the der(5) described here. Fig. 7 summarizes the c-myc sequence data from the alkaline lysate and the CHEF techniques. As can be seen in this figure, as the amount of c-myc in the episome decreases, there is an increase in c-myc sequences in double-minute DNA. As the amount of c-myc sequences on the DMs decrease the amount of c-myc sequences present on chromosomal DNA increases. We have now followed these cells with karyotype examination and CHEF gels for 26 additional passages (up to passage 100) and to date have found no evidence of transfer of the c-myc sequences back into the double minute or episomal compartments.
Effect of movement of c-myc on cell-doubling time. The populations doubling times of the HL-60 cells were followed with increasing passage number. As can be seen in Table I, 7 and no DM-containing cells were observed. All of these prior studies as well as the present study suggest a selection for HSR-or ABR-bearing cells with increasing passages in culture. Other workers have recognized a variety of changes in the cytogenetics of the HL-60 cell line over time. Gallagher and colleagues (44) noted the tumor from the patient and the cell line (passages 6-55) had only "occasionally observed" cells with DMs. Other abnormalities included deletion of chromosomes X, 5, 8, and 17 with the appearance ofa submetacentric marker chromosome (M3).
Norwell and colleagues (45) examined karyotypes of HL-60 cells frozen in 1978 and found in their cells (passage number not given), that "nearly all metaphases contained numerous DMs." In HL-60 cells frozen 1 year later (1979) , they noted a normal chromosome 8 had been replaced with an 8q+ chromosome with an abnormal banding pattern (45) . Of particular note, DMs were not observed in any of the cells. These findings were also noted in HL-60s kept in continuous passage since 1978. Thus they presented indirect evidence that c-myc was amplified in the HL-60 leukemia line originally in DMs which progressed to c-myc amplification on an abnormal banding region on 8q. This finding of amplification of c-myc on an ABR on chromosome 8 was of particular note because later the native locus of c-myc was found to be 8q24 (46) (47) (48) .
Wolman and colleagues (34) studied approximately passage 50 of the HL-60 line. They noted a modal chromosome number of 45 with losses of no. 5, no. 17, and X, and a gain of no. 18 and the presence of a number of markers including an M3q+. They found no cells with multiple minutes and noted fewer than 1% of metaphases had possible DMs. The M3q+ was interpreted as a translocation t(5p; 17q). The ABRs on M3q+ were found to be the site of the amplified c-myc. They concluded the breakpoint on chromosome 17 in 17q21 was the area where the c-myc DNA sequences were inserted. Basically their work documented that, if DMs do integrate into a chromosome, "it is not obligatory that the native region ofthe gene be involved in the integration event" (34) . They postulated that the mobile form of the c-myc will seek a region susceptible to breakage or "take advantage of ongoing breakage and reunion events." Our data indicate that the c-myc sequences on the double minutes incorporated into a duplicated chromosome, supporting the concept that it make take a duplication event to get incorporation.
Misawa et al. (49) recently examined HL-60 cell lines (passages not designated) one of which had the ABR on chromosome 8 (with no DMs), reported by Nowell et al. (45) , while the other had DMs but no abnormality of chromosome 8. In situ hybridization studies demonstrated localization of c-myc to the ABR in the one cell line and to the DMs in the other. These data were consistent with the concept that these chromosomal abberations were interchangeable.
As noted above, gene amplification has been described for both oncogenes and drug resistance genes in patients' tumors. The two cytogenetic manifestations of gene amplification are double minutes and homogeneously staining regions (also known as expanded chromosomal regions or abnormally banding regions). Since DMs do not have a centromere they segregate randomly at each mitosis and consequently are lost from the population over time unless there is some selective pressure to give cells with amplified sequences on DMs a growth advantage. On the other hand, if amplified sequences are located on expanded chromosomal regions (HSRs), they segregate normally during mitosis and are probably not lost even in the absence of selection ( 1, 11, 23) .
In the present study we have identified a time in the passage of HL-60 human promyelocytic leukemia cells during which the c-myc sequences are located on extrachromosomal sites (first on episomes, then later on DMs). It is conceivable these c-myc sequences might be vulnerable to loss while they are on these extrachromosomal sites. Loss of the c-myc sequences could be associated with a less aggressive biologic behavior. However, once the c-myc sequences are located on the chromosome it is unlikely the oncogene sequences can be eliminated.
Several strategies have been proposed to eliminate extrachromosomal DNA gene sequences. Therefore, knowing that oncogene sequences or drug resistance gene sequences are on extrachromosomal DNA makes a strategy for elimination of the extrachromosomal sequences (for therapeutic reasons) a possibility (20, 23, 24, 50) . Since it has recently been demonstrated that human tumors taken directly from patients more often have DMs present than HSRs, this strategy may have some clinical application (Benner, S. E., G. M. Wahl, and D. D. Von Hoff, manuscript submitted for publication).
Our work has not addressed the question of how the episomes arise. They are present in the earliest passages of the line. Wahl (23) has proposed that some insult to the cell causes perturbation of DNA synthesis which leads to stalled replication loops, excision of which result in the formation of episomes. As of now, there is no definite proof this is the case. However, it is an area of active investigation.
